Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 3)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Squamous Cell (Phase 3)

Cholangiocarcinoma (Phase 2)

Colorectal Neoplasms (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Esophageal Neoplasms (Phase 2)

Esophageal Squamous Cell Carcinoma (Phase 3)

Graft vs Host Disease (Phase 2)

Hodgkin Disease (Phase 3)

Hypercholesterolemia (Phase 3)

Hyperlipoproteinemia Type II (Phase 3)

Leukemia (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Lung Diseases (Phase 2)

Lung Neoplasms (Phase 3)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 3)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Lymphoma, Extranodal NK-T-Cell (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 3)

Lymphoma, T-Cell (Phase 2)

Macular Degeneration (Phase 1)

Melanoma (Phase 3)

Microsatellite Instability (Phase 2)

Myelodysplastic Syndromes (Phase 1)

Nasopharyngeal Carcinoma (Phase 3)

Nasopharyngeal Neoplasms (Phase 3)

Necrosis (Phase 1)

Neoplasms (Phase 2)

Obesity (Phase 2)

Overweight (Phase 2)

Preleukemia (Phase 1)

Respiratory Tract Diseases (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Spondylitis (Phase 3)

Spondylitis, Ankylosing (Phase 3)

Stomach Neoplasms (Phase 3)

Syndrome (Phase 1)

Thoracic Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Wet Macular Degeneration (Phase 1)